ALLENA PHARMACEUTICALS
Allena Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
ALLENA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.allenapharma.com
Total Employee:
101+
Status:
Active
Contact:
215-791-0105
Email Addresses:
[email protected]
Total Funding:
148.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pontifax
Pontifax investment in Post-IPO Debt - Allena Pharmaceuticals
Bessemer Venture Partners
Bessemer Venture Partners investment in Post-IPO Equity - Allena Pharmaceuticals
Partner Fund Management
Partner Fund Management investment in Series C - Allena Pharmaceuticals
Wellington Management
Wellington Management investment in Series C - Allena Pharmaceuticals
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Allena Pharmaceuticals
Inbio Ventures
Inbio Ventures investment in Series C - Allena Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Allena Pharmaceuticals
Bessemer Venture Partners
Bessemer Venture Partners investment in Series B - Allena Pharmaceuticals
Inbio Ventures
Inbio Ventures investment in Series B - Allena Pharmaceuticals
Pharmstandard
Pharmstandard investment in Series B - Allena Pharmaceuticals
Official Site Inspections
http://www.allenapharma.com Semrush global rank: 3.01 M Semrush visits lastest month: 5.4 K
Unable to get host informations!!!
